These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 3061640)
1. Antioestrogens in the management of hormone-dependent cancer. Litherland S; Jackson IM Cancer Treat Rev; 1988 Sep; 15(3):183-94. PubMed ID: 3061640 [No Abstract] [Full Text] [Related]
2. Clinical studies with aminoglutethimide in advanced breast carcinoma. Harvey HA; Lipton A; Santen RJ Acta Clin Belg Suppl; 1986; 11():29-40. PubMed ID: 3459321 [No Abstract] [Full Text] [Related]
3. The biological evaluation of novel antioestrogens for the treatment of breast cancer. Chander SK; Sahota SS; Evans TR; Luqmani YA Crit Rev Oncol Hematol; 1993 Dec; 15(3):243-69. PubMed ID: 8142059 [No Abstract] [Full Text] [Related]
4. [Tamoxifen and breast cancer: is everything known already?]. Marchetti P; Porzio G; Trapasso T; Baldi PL; Ficorella C Tumori; 1998; 84(6):A1-5. PubMed ID: 10080686 [No Abstract] [Full Text] [Related]
5. Interactions of antioestrogens and aromatase inhibitors. Schmid P; Possinger K Forum (Genova); 2002; 12(1):45-59. PubMed ID: 12634910 [TBL] [Abstract][Full Text] [Related]
6. Recent advances in endocrine therapy of breast cancer. Howell A; Dowsett M BMJ; 1997 Oct; 315(7112):863-6. PubMed ID: 9353509 [No Abstract] [Full Text] [Related]
7. [Estrogen antagonists and inhibitors in hormone therapy of breast cancer]. Dryzhak VI Vopr Onkol; 1989; 35(7):771-8. PubMed ID: 2528239 [No Abstract] [Full Text] [Related]
8. New stars in the sky of treatment for early breast cancer. Piccart-Gebhart MJ N Engl J Med; 2004 Mar; 350(11):1140-2. PubMed ID: 15014188 [No Abstract] [Full Text] [Related]
9. The duration of adjuvant tamoxifen therapy. Bilimoria MM; Jordan VC Cancer Treat Res; 1998; 94():181-93. PubMed ID: 9587688 [No Abstract] [Full Text] [Related]
10. Endocrine therapy of endometrial cancer. Lentz SS Cancer Treat Res; 1998; 94():89-106. PubMed ID: 9587684 [No Abstract] [Full Text] [Related]
11. Ovarian ablation as adjuvant therapy for early-stage breast cancer. Pritchard KI Cancer Treat Res; 1998; 94():158-80. PubMed ID: 9587687 [No Abstract] [Full Text] [Related]
12. Searching for the ideal SERM. Poletti A Pharmacol Res; 1999 May; 39(5):333. PubMed ID: 10328989 [No Abstract] [Full Text] [Related]
13. Re: Tamoxifen and chemotherapy for lymph node-negative, estrogen receptor-positive breast cancer. Atkins CD J Natl Cancer Inst; 1998 Mar; 90(6):468-9. PubMed ID: 9521174 [No Abstract] [Full Text] [Related]
14. Strategies for breast cancer therapy with antiestrogens. Jordan VC; Fritz NF; Gottardis MM J Steroid Biochem; 1987; 27(1-3):493-8. PubMed ID: 3320539 [TBL] [Abstract][Full Text] [Related]
15. [Therapeutic results obtained with aminoglutethimide in advanced-stage breast cancer. Factors predictive of a response]. Paridaens RJ; Arrigo C; Heuson JC Acta Clin Belg Suppl; 1986; 11():18-28. PubMed ID: 3459320 [No Abstract] [Full Text] [Related]
16. Effect of tamoxifen on GH and IGF-1 serum level in stage I-II breast cancer patients. Mandalà M; Moro C; Ferretti G; Calabro MG; Nolè F; Rocca A; Munzone E; Castro A; Curigliano G Anticancer Res; 2001; 21(1B):585-8. PubMed ID: 11299809 [TBL] [Abstract][Full Text] [Related]
17. Development of new drugs for endocrine tumour chemotherapy. von Angerer E Cancer Treat Rev; 1984 Mar; 11 Suppl A():147-53. PubMed ID: 6547370 [No Abstract] [Full Text] [Related]
18. Chemosensitizing effect of tamoxifen and ICI 182,780 on parental and adriamycin-resistant MCF-7 human breast cancer cells. de Vincenzo R; Scambia G; Benedetti Panici P; Bonanno G; Ercoli A; Fattorossi A; Pernisco S; Isola G; Mancuso S Ann N Y Acad Sci; 1996 Apr; 784():517-20. PubMed ID: 8651609 [No Abstract] [Full Text] [Related]